Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model-Reference-Cited by-同舟云学术

Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model

Published:2021-06 Issue: Volume:901 Page:174078
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bedi Onkar,Srivastava Niharika,Parsad Davinder,Krishan Pawan

Publisher

Elsevier BV

Subject

Pharmacology

Reference29 articles.

1. The effects of solvent polarity on hypoglycemic and hypolipidemic activities of vaccinium arctostaphylos L. Unripe fruits;Ahmadi;Pharm. Chem. J.,2017

2. Molecular and pathological events involved in the pathogenesis of diabetes associated non-alcoholic fatty liver disease;Bedi;J Clin Exp Hepatol,2019

3. In-vitro targeted screening and molecular docking of stilbene, quinones, and flavonoid on 3T3-L1 pre-adipocytes for anti- adipogenic actions;Bedi;N-S Arch Pharmacol,2020

4. Investigations on acute oral toxicity studies of purpurin by application of OECD guideline 423 in rodents;Bedi;N-S Arch Pharmacol.,2019

5. Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes;Bhakkiyalakshmi;Eur. J. Pharmacol.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruption of gut barrier integrity and host–microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus;Gut Microbes;2024-01-18

2. A lipidomic approach to bisphenol F-induced non-alcoholic fatty liver disease-like changes: altered lipid components in a murine model;Environmental Science and Pollution Research;2023-10-14

3. Steviol glycosides from Stevia rebaudiana Bertoni mitigate lipid metabolism abnormalities in diabetes by modulating selected gene expression – An in vivo study;Biomedicine & Pharmacotherapy;2023-10

4. Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation;European Journal of Pharmacology;2022-10

5. Oral Administration of Bacillus toyonensis Strain SAU-20 Improves Insulin Resistance and Ameliorates Hepatic Steatosis in Type 2 Diabetic Mice;Frontiers in Immunology;2022-02-15